GSP Crop Science has debuted at Rs 332.30 on the BSE, up by 12.3 points or 3.84% from its issue price of Rs 320.00.
The scrip is currently trading at Rs. 331.95, up by 11.95 points or 3.73% from its issue price.
It has touched a high and low of Rs. 362.30 and Rs. 327.35 respectively. So far 2.38 lakh shares were traded on the counter.
The offering, which was open for subscription between March 16, 2026 and March 18, 2026 was subscribed 1.64 times. The issue price was fixed at Rs 320.00 per share i.e. at upper end of price band of Rs 304-320 apiece.
GSP Crop Science is a research-driven agrochemical company, specializing in the development and manufacturing of insecticides, herbicides, fungicides and plant growth regulators in India.
| Company Name | CMP |
|---|---|
| UPL | 654.15 |
| PI Industries | 3021.10 |
| Bayer CropScience | 4828.50 |
| Sharda Cropchem | 1108.70 |
| Sumitomo Chemical | 439.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: